Table 3.
Study | MINORS criteria |
||||||||
---|---|---|---|---|---|---|---|---|---|
Clearly stated aim | Inclusion of consecutive patients | Prospective collection of data | Endpoints appropriate to the aims of the study | Unbiased assessment of the study endpoint | Follow-up period appropriate to the aim of the study | Loss to follow-up less than 5% | Prospective calculation of the study size | Total | |
Wolters 2011 | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 0 | 12 |
Muto 2014 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 13 |
Migliari 2015 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 14 |
Hurle 2020 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 0 | 13 |
Soria 2020 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | 14 |
Yang 2020 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 14 |
Zhou 2020 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 14 |
Xu 2021 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 0 | 13 |